Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lupus nephritis
lupus nephritis
Kezar to discontinue mid-stage trial for lupus treatment
Reuters
Thu, 10/17/24 - 09:22 am
Kezar Life Sciences
clinical trials
lupus nephritis
autoimmune hepatitis
FDA places hold on Kezar Life Sciences’ trial for lupus nephritis treatment
Clinical Trials Arena
Mon, 10/7/24 - 11:29 am
Kezar Life Sciences
lupus nephritis
FDA
zetomipzomib
clinical trials
Roche looks to grow Gazyva's reach with phase 3 lupus nephritis win
Fierce Pharma
Thu, 09/26/24 - 06:27 pm
Roche
Gazyva
clinical trials
lupus nephritis
Kyverna Files First IND to Leverage CAR-T Therapy for Lupus
BioSpace
Thu, 10/20/22 - 10:32 am
Kyverna Therapeutics
KYV-101
CAR-T
lupus nephritis
As GSK, Aurinia heat up the lupus nephritis category, analyst gauges doctors' first impressions
Fierce Pharma
Thu, 06/24/21 - 11:11 am
GSK
Aurinia
lupus nephritis
Benlysta
Lupkynis
FDA
Catalent signs on to produce Aurinia's newly approved lupus nephritis drug
Fierce Pharma
Mon, 02/22/21 - 10:46 am
Catalent
Aurinia Pharmaceuticals
lupus nephritis
Lupkynis
CDMOs
Here’s Why the Approval of Lupkynis Has Biotech Investors Buzzing
Xtalks
Mon, 02/1/21 - 10:52 am
FDA
Aurinia Pharmaceuticals
Lupkynis
voclosporin
lupus nephritis
Aurinia snags FDA approval for lupus nephritis med Lupkynis, its first drug launch
Fierce Pharma
Sat, 01/23/21 - 11:46 pm
Aurinia
FDA
Lupkynis
voclosporin
lupus nephritis
After losing race for first to market in lupus nephritis, Aurinia taps Otsuka for voclosporin licensing pact abroad
Endpoints
Thu, 12/17/20 - 06:18 pm
Aurinia Pharmaceuticals
lupus nephritis
GSK
Otsuka
Benlysta
Aurinia announces FDA acceptance of NDA filing and priority review for voclosporin to treat lupus nephritis
Pharmaceutical Business Review
Wed, 07/22/20 - 10:41 am
Aurinia
voclosporin
FDA
lupus nephritis
Aurinia initiates rolling submission of a new drug application to the FDA for Voclosporin in the treatment of lupus nephritis
Pharmaceutical Business Review
Tue, 03/17/20 - 12:12 pm
Aurinia Pharmaceuticals
FDA
voclosporin
lupus nephritis
Aurinia’s drug to treat autoimmune kidney disease hits its goals in late-stage trial
Stat
Wed, 12/4/19 - 11:15 pm
Aurinia Pharmaceuticals
lupus nephritis
clinical trials
voclosporin
autoimmune kidney disease
Here’s Why Aurinia Pharmaceuticals Stock Jumped Higher Today
Motley Fool
Tue, 11/26/19 - 11:44 pm
Aurinia Pharmaceuticals
clinical trials
voclosporin
lupus nephritis
After touting Gazyva's potential in lupus, Roche nabs 'breakthrough' ahead of PhIII
Endpoints
Wed, 09/18/19 - 10:02 am
Roche
Gazyva
lupus nephritis
Roche touts phase 2 Gazyva data in lupus patients with a potentially fatal kidney complication
Fierce Pharma
Tue, 06/11/19 - 06:32 pm
Roche
FDA
lupus nephritis
Gazyva
New Data Suggests Aurinia Pharmaceuticals Is Onto Something Big
Motley Fool
Wed, 06/21/17 - 09:40 am
Aurinia Pharmaceuticals
voclosporin
CellCept
lupus nephritis